Raymond James Financial’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5M Sell
1,668,730
-186,823
-10% -$2.9M 0.01% 1358
2026
Q1
$25.1M Buy
1,855,553
+356,463
+24% +$4.99M 0.01% 1309
2025
Q4
$18.7M Sell
1,499,090
-157,153
-9% -$1.7M 0.01% 1497
2025
Q3
$16.4M Buy
1,656,243
+67,874
+4% +$661K 0.01% 1544
2025
Q2
$14.2M Sell
1,588,369
-111,159
-7% -$940K ﹤0.01% 1615
2025
Q1
$14.8M Sell
1,699,528
-96,289
-5% -$1.01M 0.01% 1522
2024
Q4
$22.4M Buy
+1,795,817
New +$22.1M 0.01% 1223

Other funds holding VTRS

Raymond James Financial's VTRS Position: Q2 2026 in Review

Raymond James Financial reduced its Viatris (VTRS) stake by 10% in Q2 2026, selling an estimated $2.9M and leaving 1,668,730 shares worth $26.5M. The position accounts for 0.01% of the portfolio, ranked #1358.

Raymond James Financial first reported a position in VTRS in Q4 2024 and has held it in 7 quarters since. 1,033 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Raymond James Financial held 1,668,730 shares of Viatris worth $26.5M as of Q2 2026.
  • Raymond James Financial sold 186,823 Viatris shares in Q2 2026, an estimated $2.9M.
  • Viatris made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1358 holding.
  • Raymond James Financial first reported a position in Viatris in Q4 2024 and has held it in 7 quarters since.
  • 1,033 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.